000143985 001__ 143985
000143985 005__ 20240229112613.0
000143985 0247_ $$2doi$$a10.1080/0284186X.2018.1557340
000143985 0247_ $$2pmid$$apmid:30736716
000143985 0247_ $$2ISSN$$a0284-186X
000143985 0247_ $$2ISSN$$a1100-1704
000143985 0247_ $$2ISSN$$a1651-226X
000143985 0247_ $$2ISSN$$a1651-2499
000143985 037__ $$aDKFZ-2019-01542
000143985 041__ $$aeng
000143985 082__ $$a610
000143985 1001_ $$0P:(DE-He78)24fe6057396bec79d2638615b12eb989$$aThong, Melissa$$b0$$eFirst author$$udkfz
000143985 245__ $$aAge-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls - a population-based study.
000143985 260__ $$aAbingdon$$bTaylor & Francis Group$$c2019
000143985 3367_ $$2DRIVER$$aarticle
000143985 3367_ $$2DataCite$$aOutput Types/Journal article
000143985 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1561444615_1937
000143985 3367_ $$2BibTeX$$aARTICLE
000143985 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143985 3367_ $$00$$2EndNote$$aJournal Article
000143985 520__ $$aBackground: Previous research suggests an age differential in health-related quality of life (HRQOL) among long-term (5-10 years post-diagnosis, LTS) colorectal cancer (CRC) survivors. Few studies have specifically addressed the association of age differentials with HRQOL for very long-term CRC survivors (>10 years post-diagnosis, VLTS) and non-cancer population controls. We aimed to assess possible deficits in HRQOL of disease-free CRC-LTS and CRC-VLTS in comparison with non-cancer population controls, and whether the observed pattern varies by age and time since diagnosis. Methods: We used data from the CAncEr Survivorship - A multi-Regional (CAESAR+) study in collaboration with five population-based German cancer registries. HRQOL from controls was accessed from the Lebensqualität in DEeutschland (LinDE) study. All respondents completed the European Organization for Research and Treatment of Cancer Quality of Life Core-30 questionnaire. We calculated least square means of HRQOL scores. Analyses were adjusted for age, sex, and education, where appropriate. Results: The sample included 862 CRC-LTS, 400 CRC-VLTS and 1689 controls. CRC survivors reported overall good HRQOL but significantly poorer social functioning and more problems with dyspnea, constipation, diarrhea and finances than controls. When stratified by age, deficits in functioning and global health, and more problems with symptoms and finances were noted mainly among younger CRC survivors. Further stratification by time since diagnosis showed that similar deficits in HRQOL and symptoms were noted mainly among the younger CRC-LTS group when compared with controls. Generally, CRC-VLTS reported comparable HRQOL to controls. An exception was noted for diarrhea, whereby CRC survivors, regardless of age and time since diagnosis, reported significantly more problems with this symptom than controls. Conclusions: In comparison with non-cancer controls, disease-free CRC survivors reported overall good HRQOL but experience persistent specific detriments in HRQOL many years after diagnosis. In age stratified analyses, HRQOL deficits were noted mainly among younger CRC-LTS.
000143985 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000143985 588__ $$aDataset connected to CrossRef, PubMed,
000143985 7001_ $$0P:(DE-He78)13aa5fe9d9961c9fd67193befb0dcf88$$aKoch-Gallenkamp, Lena$$b1$$udkfz
000143985 7001_ $$0P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aJansen, Lina$$b2$$udkfz
000143985 7001_ $$aBertram, Heike$$b3
000143985 7001_ $$00000-0003-4195-5236$$aEberle, Andrea$$b4
000143985 7001_ $$aHolleczek, Bernd$$b5
000143985 7001_ $$aWaldeyer-Sauerland, Mechthild$$b6
000143985 7001_ $$00000-0002-5909-9936$$aWaldmann, Annika$$b7
000143985 7001_ $$00000-0002-0743-6128$$aZeissig, Sylke Ruth$$b8
000143985 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b9$$udkfz
000143985 7001_ $$0P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aArndt, Volker$$b10$$eLast author$$udkfz
000143985 773__ $$0PERI:(DE-600)1492623-4$$a10.1080/0284186X.2018.1557340$$gVol. 58, no. 5, p. 801 - 810$$n5$$p801 - 810$$tActa oncologica$$v58$$x0001-6926$$y2019
000143985 909CO $$ooai:inrepo02.dkfz.de:143985$$pVDB
000143985 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)24fe6057396bec79d2638615b12eb989$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000143985 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)13aa5fe9d9961c9fd67193befb0dcf88$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000143985 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000143985 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000143985 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000143985 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000143985 9141_ $$y2019
000143985 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000143985 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143985 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143985 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bACTA ONCOL : 2017
000143985 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000143985 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000143985 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000143985 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143985 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000143985 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143985 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143985 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000143985 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000143985 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000143985 9201_ $$0I:(DE-He78)C071-20160331$$kC071$$lCancer Survivorship$$x0
000143985 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x1
000143985 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x2
000143985 980__ $$ajournal
000143985 980__ $$aVDB
000143985 980__ $$aI:(DE-He78)C071-20160331
000143985 980__ $$aI:(DE-He78)C070-20160331
000143985 980__ $$aI:(DE-He78)L101-20160331
000143985 980__ $$aUNRESTRICTED